Skip to main content
Tuberculosis: Doctors Without Borders launches unprecedented project to tackle underdiagnosis among children
India
Tuberculosis: Doctors Without Borders launches unprecedented project to tackle underdiagnosis among children
Tuberculosis (TB) in children is a silent scourge: one child dies of tuberculosis every three minutes and more than half of all children with TB are n...
结核病 (TB)
病者有其药项目
Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
India
Landmark Clinical Trial Redefines Multidrug-Resistant Tuberculosis Treatment Options
endTB Clinical Trial Offers Multiple New Shortened Drug Regimens to Treat Adults and Children with Multidrug-Resistant Tuberculosis
结核病 (TB)
Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
India
Doctors Without Borders calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug, main patent expires in India today
Recent deal offering controlled generics access in limited countries does not go far enough.
结核病 (TB)
病者有其药项目
India’s COVID-19 crisis shows urgency for countries to back the waiver for vaccine patents
India
India’s COVID-19 crisis shows urgency for countries to back the waiver for vaccine patents
Hong Kong - The second wave of COVID-19 is reaching extremely alarming levels in India. As of 18 May, the total number of active COVID-19 cases in Ind...
新冠肺炎
Four questions on India’s second wave of COVID-19
India
Four questions on India’s second wave of COVID-19
The second wave of COVID-19 in India has been devastating, with a catastrophic rise in the numbers of new infections in recent weeks. The country has ...
新冠肺炎
COVID-19: Responding to India’s second wave
India
COVID-19: Responding to India’s second wave
Doctors Without Borders/Médecins Sans Frontières (MSF) restarts emergency response amid a surging second wave of COVID-19 in Mumbai in Maharashtra sta...
新冠肺炎